MartinBertLeonMD
Cardiology • New York, NYAdult Congenital Heart Disease, Interventional Cardiology
Professor, Medicine, Columbia University College of Phys & Surg
Overview of Dr. Leon
Dr. Martin Leon is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Lawrence Hospital. He received his medical degree from Yale School of Medicine and has been in practice 47 years. He is one of 322 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 695 doctors at New York-Presbyterian Hospital who specialize in Cardiology. He has more than 100 publications and over 500 citings.
Office
161 Fort Washington Avenue
New York, NY 10032
Education & Training
Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 1980 - 1982- Yale-New Haven Medical CenterResidency, Internal Medicine, 1975 - 1978
Yale School of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1982 - Present
NY State Medical License 1999 - 2026
MD State Medical License 1979 - 2002
DC State Medical License 1989 - 2000
PA State Medical License 1994 - 2000
CT State Medical License 1977 - 1982- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 175 citationsClinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience.Tamim Nazif, Mathew R. Williams, Rebecca T. Hahn, Samir R. Kapadia, Vasilis Babaliaros
European Heart Journal. 2014-06-21 - 6 citationsUtilization, Costs, and Outcomes of Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement.Howard C. Herrmann, David Cohen, Rebecca T. Hahn, Vasilis Babaliaros, Xiao Yu
Circulation. Cardiovascular Interventions. 2021-06-16 - 60 citationsLatent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.Barry A Borlaug, John Blair, Martin W Bergmann, Heiko Bugger, Dan Burkhoff
Circulation. 2022-05-24
Press Mentions
FDA Clears New Device for Valve-in-Valve TAVR Patients at Risk of Coronary ObstructionSeptember 30th, 2024- Pi-Cardia Receives FDA Market Clearance for ShortCut Dedicated Leaflet Modification Device to Enable TAVR in Patients at Risk of Coronary ObstructionSeptember 30th, 2024
- MedTech & Irrus Syndicates Lead Study Funding for CroiValve's Transcatheter Tricuspid DeviceSeptember 5th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
